• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Maspin在野生型和突变型胃癌中的亚细胞表达。

Maspin subcellular expression in wild-type and mutant gastric cancers.

作者信息

Gurzu Simona, Jung Ioan, Sugimura Haruhiko, Stefan-van Staden Raluca Ioana, Yamada Hidetaka, Natsume Hiroko, Iwashita Yuji, Szodorai Rita, Szederjesi Janos

机构信息

Department of Pathology, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, Targu Mureș 540139, Mureș, Romania.

Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.

出版信息

World J Gastrointest Oncol. 2020 Jul 15;12(7):741-755. doi: 10.4251/wjgo.v12.i7.741.

DOI:10.4251/wjgo.v12.i7.741
PMID:32864042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7428795/
Abstract

BACKGROUND

Although the role of p53 in the evolution and prognosis of gastric cancer (GC) has been extensively examined, the exact mechanism of action is incompletely understood. In the last years, p53-target genes were supposed to be involved in the p53 pathway. One of them is the tumor-suppressor gene Maspin, which codifies the protein with the same name. Maspin activity depends on its subcellular localization. To our knowledge, the possible role of gene in Maspin subcellular localization, in GC cells, has not yet been studied in a large number of human samples.

AIM

To evaluate the possible role of wild-type and mutated p53 in Maspin subcellular localization.

METHODS

The present study included 266 consecutive patients with GC in which gene status, and mutations in exons 2 to 11, respectively, were analyzed and correlated with immunohistochemical expression of p53 and Maspin.

RESULTS

None of the 266 cases showed mutations in exon 9. The rate of mutations was 33.83%. The mutation rate was slightly higher in distally-located GCs, with a lower degree (≤ 5 buds/ high power fields) of dyscohesivity ( < 0.01). The wild-type cases had a longer survival, compared with mutant GCs, especially in patients without lymph node metastases, despite the high depth of tumor infiltration ( = 0.01). The Dukes-MAC-like staging system was proved to have the most significant independent prognostic value ( < 0.01). The statistical correlations proved that gene mutations in exon 7 might induce knockdown of Maspin, but wild-type p53 can partially restore nuclear Maspin expression and decrease the metastatic potential of gastric adenocarcinoma cells.

CONCLUSION

Downregulated Maspin might be induced by mutations in exon 7 of the gene but wild-type p53 can partially restore nuclear Maspin expression. These findings should be proved in experimental studies.

摘要

背景

尽管p53在胃癌(GC)的发生发展及预后中的作用已得到广泛研究,但其确切作用机制仍未完全明确。近年来,p53靶基因被认为参与p53信号通路。其中之一是肿瘤抑制基因Maspin,它编码同名蛋白质。Maspin的活性取决于其亚细胞定位。据我们所知,在大量人类样本中,尚未研究该基因在GC细胞中Maspin亚细胞定位方面的可能作用。

目的

评估野生型和突变型p53在Maspin亚细胞定位中的可能作用。

方法

本研究纳入266例连续的GC患者,分析其基因状态以及外显子2至11的突变情况,并与p53和Maspin的免疫组化表达进行相关性分析。

结果

266例病例中无一例显示外显子9突变。基因的突变率为33.83%。远端GC的突变率略高,黏附性差的程度较低(≤5个芽/高倍视野)(<0.01)。与突变型GC相比,野生型病例的生存期更长,尤其是在无淋巴结转移的患者中,尽管肿瘤浸润深度较深(=0.01)。Dukes-MAC样分期系统被证明具有最显著的独立预后价值(<0.01)。统计相关性证明,外显子7的基因突变可能导致Maspin表达下调,但野生型p53可部分恢复Maspin的核表达并降低胃腺癌细胞的转移潜能。

结论

Maspin表达下调可能由基因外显子7的突变诱导,但野生型p53可部分恢复Maspin的核表达。这些发现应在实验研究中得到证实。

相似文献

1
Maspin subcellular expression in wild-type and mutant gastric cancers.Maspin在野生型和突变型胃癌中的亚细胞表达。
World J Gastrointest Oncol. 2020 Jul 15;12(7):741-755. doi: 10.4251/wjgo.v12.i7.741.
2
Maspin and p53 protein expression in gastric adenocarcinoma and its clinical applications.Maspin和p53蛋白在胃腺癌中的表达及其临床应用。
Appl Immunohistochem Mol Morphol. 2008 Jan;16(1):13-8. doi: 10.1097/PAI.0b013e31802c4f21.
3
Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.Maspin缺失是结直肠癌的一个有用的预后指标:组织芯片分析
Pathol Res Pract. 2005;200(11-12):783-90. doi: 10.1016/j.prp.2004.10.004.
4
Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF).Maspin在早期口腔舌癌中的表达及其与突变型p53和血管内皮生长因子(VEGF)表达的关系。
Oral Oncol. 2007 Mar;43(3):272-7. doi: 10.1016/j.oraloncology.2006.03.018. Epub 2006 Dec 14.
5
Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features.原发性前列腺癌中p53和Maspin蛋白的表达:与临床特征的相关性。
Int J Cancer. 2001 Sep 20;95(5):337-42. doi: 10.1002/1097-0215(20010920)95:5<337::aid-ijc1059>3.0.co;2-1.
6
Maspin in thyroid cancer: its relationship with p53 and clinical outcome.乳腺丝抑蛋白在甲状腺癌中的作用:其与p53的关系及临床结局
Oncol Rep. 2003 Nov-Dec;10(6):1783-7.
7
[Expression of maspin protein and correlation between maspin and P53 proteins in gastric carcinoma].[Maspin蛋白在胃癌中的表达及其与P53蛋白的相关性]
Zhonghua Yi Xue Za Zhi. 2007 Apr 3;87(13):909-12.
8
p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.p53和Ki-ras作为Dukes B期结直肠癌的预后因素。
Eur J Cancer. 2000 May;36(8):1008-15. doi: 10.1016/s0959-8049(00)00036-8.
9
Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.肿瘤抑制基因maspin在非小细胞肺癌中的预后意义
Ann Thorac Surg. 2005 Jan;79(1):248-53. doi: 10.1016/j.athoracsur.2004.06.118.
10
Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer.免疫基因组学分析表明TP53突变抑制胃癌中的肿瘤免疫。
Transl Oncol. 2018 Oct;11(5):1171-1187. doi: 10.1016/j.tranon.2018.07.012. Epub 2018 Jul 27.

引用本文的文献

1
The paradoxical role of SERPINB5 in gastrointestinal cancers: oncogene or tumor suppressor?丝氨酸蛋白酶抑制剂B5(SERPINB5)在胃肠道癌症中的矛盾作用:癌基因还是肿瘤抑制因子?
Mol Biol Rep. 2025 Feb 3;52(1):188. doi: 10.1007/s11033-025-10293-w.
2
Bioinformatic Identification of TP53 Gene Mutation Hotspots in Colorectal Cancer.生物信息学鉴定结直肠癌中 TP53 基因突变热点。
Int J Mol Sci. 2024 Jun 15;25(12):6612. doi: 10.3390/ijms25126612.
3
Significance of concurrent evaluation of HER2 gene amplification and p53 and Ki67 expression in gastric cancer tissues.

本文引用的文献

1
Immunohistochemical-based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial-mesenchymal transition.基于免疫组织化学的结直肠癌分子亚型分类:使用maspin和上皮-间质转化标志物
Oncol Lett. 2020 Feb;19(2):1487-1495. doi: 10.3892/ol.2019.11228. Epub 2019 Dec 18.
2
Maspin is a PTEN-Upregulated and p53-Upregulated Tumor Suppressor Gene and Acts as an HDAC1 Inhibitor in Human Bladder Cancer.Maspin是一种PTEN上调和p53上调的肿瘤抑制基因,在人类膀胱癌中作为组蛋白去乙酰化酶1(HDAC1)抑制剂发挥作用。
Cancers (Basel). 2019 Dec 18;12(1):10. doi: 10.3390/cancers12010010.
3
Transgelin, a p53 and PTEN-Upregulated Gene, Inhibits the Cell Proliferation and Invasion of Human Bladder Carcinoma Cells in Vitro and in Vivo.
胃癌组织中HER2基因扩增与p53及Ki67表达同步评估的意义
Clin Transl Oncol. 2025 Jan;27(1):126-134. doi: 10.1007/s12094-024-03534-0. Epub 2024 Jun 22.
4
TP53 mutations in Romanian patients with colorectal cancer.罗马尼亚结直肠癌患者中的TP53突变
Genes Environ. 2023 Jul 1;45(1):20. doi: 10.1186/s41021-023-00277-2.
5
Integrating the tumor-suppressive activity of Maspin with p53 in retuning the epithelial homeostasis: A working hypothesis and applicable prospects.在恢复上皮内稳态过程中整合Maspin与p53的肿瘤抑制活性:一个工作假说及应用前景。
Front Oncol. 2022 Nov 29;12:1037794. doi: 10.3389/fonc.2022.1037794. eCollection 2022.
6
Characterization and clinical evaluation of microsatellite instability and loss of heterozygosity in tumor-related genes in gastric cancer.胃癌中肿瘤相关基因的微卫星不稳定性和杂合性缺失的特征及临床评估
Oncol Lett. 2021 Jun;21(6):430. doi: 10.3892/ol.2021.12691. Epub 2021 Mar 30.
7
Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.胃癌中与免疫微环境及预后相关的干性特征鉴定
Front Oncol. 2021 Mar 3;11:626961. doi: 10.3389/fonc.2021.626961. eCollection 2021.
8
Subcellular Expression of Maspin in Colorectal Cancer: Friend or Foe.抑癌蛋白maspin在结直肠癌中的亚细胞表达:助力还是阻力
Cancers (Basel). 2021 Jan 20;13(3):366. doi: 10.3390/cancers13030366.
9
HER2 Heterogeneity in Gastric Cancer: A Comparative Study, Using Two Commercial Antibodies.胃癌中HER2的异质性:使用两种商业抗体的比较研究
J Oncol. 2020 Oct 20;2020:8860174. doi: 10.1155/2020/8860174. eCollection 2020.
转胶蛋白(Transgelin)是一个受 p53 和 PTEN 调控的基因,可抑制人膀胱癌在体外和体内的细胞增殖和侵袭。
Int J Mol Sci. 2019 Oct 7;20(19):4946. doi: 10.3390/ijms20194946.
4
Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference.根据国际肿瘤芽生共识会议标准评估的胃癌肿瘤芽生的预后意义。
Histopathology. 2020 Feb;76(3):433-446. doi: 10.1111/his.13997. Epub 2019 Dec 1.
5
Prognostic implications and interaction of L1 methylation and p53 expression statuses in advanced gastric cancer.晚期胃癌中 L1 甲基化和 p53 表达状态的预后意义及相互作用。
Clin Epigenetics. 2019 May 14;11(1):77. doi: 10.1186/s13148-019-0661-x.
6
Association of Gene Mutation With Infection in Gastric Cancer Patients and Its Correlation With Clinicopathological and Environmental Factors.胃癌患者基因突变与感染的关联及其与临床病理和环境因素的相关性
World J Oncol. 2019 Feb;10(1):46-54. doi: 10.14740/wjon1087. Epub 2019 Feb 26.
7
Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.TP53 基因突变率在非裔美国胃癌患者中显著升高。
Ann Surg Oncol. 2018 Jul;25(7):2027-2033. doi: 10.1245/s10434-018-6502-x. Epub 2018 May 3.
8
Nuclear maspin expression: A biomarker for budding assessment in colorectal cancer specimens.核maspin表达:一种用于评估结直肠癌标本出芽情况的生物标志物。
Pathol Res Pract. 2017 Sep;213(9):1227-1230. doi: 10.1016/j.prp.2017.07.025. Epub 2017 Jul 24.
9
Proposal of a Dukes-MAC-like staging system for gastric cancer.一种类似Dukes-MAC分期系统的胃癌分期系统的提议。
J Investig Med. 2017 Feb;65(2):316-322. doi: 10.1136/jim-2016-000270. Epub 2016 Sep 15.
10
Immunohistochemical correlates of TP53 somatic mutations in cancer.癌症中TP53体细胞突变的免疫组织化学相关性
Oncotarget. 2016 Oct 4;7(40):64910-64920. doi: 10.18632/oncotarget.11912.